Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

SNSS

Sunesis Pharmaceuticals (SNSS)

Sunesis Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SNSS
DateTimeSourceHeadlineSymbolCompany
09/11/201212:00PMMarketwiredMarket Talk: Active Stocks to Watch - PZOO, SNSS, TNSX, CTICNASDAQ:SNSSSunesis Pharmaceuticals Inc
09/11/20129:20AMDow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS TO WATCHNASDAQ:SNSSSunesis Pharmaceuticals Inc
09/11/20128:26AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:SNSSSunesis Pharmaceuticals Inc
09/11/20126:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals to Implement One-Time Sample Size Increase to Phase 3 VALOR Trial in AMLNASDAQ:SNSSSunesis Pharmaceuticals Inc
08/27/20127:00AMGlobeNewswire Inc.Sunesis to Present at Upcoming Investor ConferencesNASDAQ:SNSSSunesis Pharmaceuticals Inc
08/09/20124:16PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:SNSSSunesis Pharmaceuticals Inc
08/09/20128:02AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:SNSSSunesis Pharmaceuticals Inc
08/09/20127:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Reports Second Quarter 2012 Financial Results and HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
08/08/20127:00AMGlobeNewswire Inc.Sunesis to Present at the 2012 Wedbush PacGrow Lifesciences Management Access ConferenceNASDAQ:SNSSSunesis Pharmaceuticals Inc
08/02/20127:00AMGlobeNewswire Inc.Sunesis to Host Conference Call on August 9th to Discuss Second Quarter Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
07/24/20127:00AMGlobeNewswire Inc.Vosaroxin Review Published in Expert Opinion on Investigational DrugsNASDAQ:SNSSSunesis Pharmaceuticals Inc
07/02/20128:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/02/20128:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/02/20128:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/02/20128:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/02/20128:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/02/20128:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/02/20128:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/02/20128:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
06/27/20127:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Receives $1.5 Million Milestone Payment From Biogen Idec Related to Kinase Inhibitor ProgramNASDAQ:SNSSSunesis Pharmaceuticals Inc
06/18/20122:43PMEdgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:SNSSSunesis Pharmaceuticals Inc
06/14/20127:00AMGlobeNewswire Inc.Data and Safety Monitoring Board Recommends Continuation of Sunesis Pharmaceuticals' VALOR Trial Based on Periodic Safety Rev...NASDAQ:SNSSSunesis Pharmaceuticals Inc
06/11/20124:31PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:SNSSSunesis Pharmaceuticals Inc
05/15/20124:18PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:SNSSSunesis Pharmaceuticals Inc
05/15/20128:03AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:SNSSSunesis Pharmaceuticals Inc
05/15/20127:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Reports First Quarter 2012 Financial Results and HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
05/08/20127:00AMGlobeNewswire Inc.Sunesis to Host Conference Call on May 15th to Discuss First Quarter Financial Results and Recent HighlightsNASDAQ:SNSSSunesis Pharmaceuticals Inc
05/03/20127:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Receives European Orphan Drug Designation for Vosaroxin to Treat Acute Myeloid LeukemiaNASDAQ:SNSSSunesis Pharmaceuticals Inc
04/23/20124:25PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:SNSSSunesis Pharmaceuticals Inc
04/23/20124:20PMEdgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:SNSSSunesis Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SNSS